Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name file name title title
tabling member	label

Search

386886

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis and Multiple Myeloma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL995
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL996 HL997 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386887

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL996
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL995 HL997 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

386888

	registered interest
	date	01/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Amyloidosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL997
	answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL995 HL996 question first answered 14/07/2015 15:34:29 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf title 2013-14 Annual Report
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

445809

	registered interest
	date	19/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what is their policy on safe staffing levels for qualified nurses in the NHS and other health and care establishments subject to Care Quality Commission or Monitor inspections.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL5219
	answer	answer is ministerial correction date of answer 01/02/2016 answer text <p>The Government is committed to supporting National Health Service trusts to put in place sustained safe staffing by using their resources as effectively as possible for patients.</p><p>Hospitals should be able to demonstrate that they are able to ensure safe, quality care for patients and that they are making the best use of resources. This should take account of patient acuity and dependency, time of day and local factors. It is therefore important for providers to take a rounded view, looking at staffing in a flexible way which is focused on the quality of care, patient safety and efficiency rather than just numbers and ratios of staff.</p><p> </p><p>The responsibility for both safe staffing and efficiency rests, as it has always done, with provider Boards.</p><p> </p><p>Comprehensive lists of research commissioned and published, of criteria in all European Union countries, Australia and the United States, each of which have a variety of systems in operation, and of discussions held by United Kingdom officials to compare patient outcomes in those countries with outcomes in England, could only be obtained at disproportionate cost.</p><p> </p><p>However, the 2013 National Quality Board (NQB) guidance on safe staffing issued in 2013 <em>How to ensure the right people, with the right skills, are in the right place at the right time: A guide to nursing, midwifery and care staffing capacity and capability, </em>referred to a number of sources of evidence on this issue. The National Institute of Health and Care Excellence (NICE) safe staffing guideline <em>Safe staffing for nursing in adult inpatient wards in acute hospitals, July 2014</em> set out the evidence and expert papers, including international evidence, that was considered in preparing the guideline. A copy of the NQB guidance and the NICE guideline are attached.</p><p> </p><p>In addition, The Department’s National Institute for Health Research (NIHR) commissions research evidence to improve the quality, accessibility and organisation of health services through the NIHR Health Services and Delivery Research programme. Current research of particular relevance to the relationship between nurse staffing levels and patient outcomes and mortality includes:</p><p> </p><p>- a study on nurse staffing levels, missed vital signs observations and mortality in hospital wards; and</p><p> </p><p>- a study on the future of 24/7 care: investigating the links between staffing levels, patient access and inequalities in health outcomes. <br></p><p>As announced by the Secretary of State on 16 July 2015, Dr Mike Durkin, National Director for Patient Safety, is working with the Chief Nursing Officer to complete the work started by NICE on safe staffing levels. Their work will draw on evidence and expert advice from England and internationally, and will be reviewed independently by NICE, the Chief Inspector of hospitals, and Sir Robert Francis to ensure it meets the high standards of care the NHS aspires to.</p><p>The programme includes revision of the NQB 2013 guidance to take account of further developments in the evidence base, the need to look beyond acute settings, new models of care leading from the Five Year Forward View and the need for providers to secure both safe staffing and greater efficiency.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name NQB guidance on safe staffing.pdf title National Quality Board safe staffing guidance 2 file name NICE safe staffing Guidance.pdf title NICE safe staffing guidance grouped question UIN HL5220 HL5221 HL5222 question first answered 01/02/2016 15:01:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

445810

	registered interest
	date	19/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what is the evidential base to support their current policy on safe staffing levels for qualified nurses, and whether they will place a copy of that evidence in the Library of the House.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL5220
	answer	answer is ministerial correction date of answer 01/02/2016 answer text <p>The Government is committed to supporting National Health Service trusts to put in place sustained safe staffing by using their resources as effectively as possible for patients.</p><p>Hospitals should be able to demonstrate that they are able to ensure safe, quality care for patients and that they are making the best use of resources. This should take account of patient acuity and dependency, time of day and local factors. It is therefore important for providers to take a rounded view, looking at staffing in a flexible way which is focused on the quality of care, patient safety and efficiency rather than just numbers and ratios of staff.</p><p> </p><p>The responsibility for both safe staffing and efficiency rests, as it has always done, with provider Boards.</p><p> </p><p>Comprehensive lists of research commissioned and published, of criteria in all European Union countries, Australia and the United States, each of which have a variety of systems in operation, and of discussions held by United Kingdom officials to compare patient outcomes in those countries with outcomes in England, could only be obtained at disproportionate cost.</p><p> </p><p>However, the 2013 National Quality Board (NQB) guidance on safe staffing issued in 2013 <em>How to ensure the right people, with the right skills, are in the right place at the right time: A guide to nursing, midwifery and care staffing capacity and capability, </em>referred to a number of sources of evidence on this issue. The National Institute of Health and Care Excellence (NICE) safe staffing guideline <em>Safe staffing for nursing in adult inpatient wards in acute hospitals, July 2014</em> set out the evidence and expert papers, including international evidence, that was considered in preparing the guideline. A copy of the NQB guidance and the NICE guideline are attached.</p><p> </p><p>In addition, The Department’s National Institute for Health Research (NIHR) commissions research evidence to improve the quality, accessibility and organisation of health services through the NIHR Health Services and Delivery Research programme. Current research of particular relevance to the relationship between nurse staffing levels and patient outcomes and mortality includes:</p><p> </p><p>- a study on nurse staffing levels, missed vital signs observations and mortality in hospital wards; and</p><p> </p><p>- a study on the future of 24/7 care: investigating the links between staffing levels, patient access and inequalities in health outcomes. <br></p><p>As announced by the Secretary of State on 16 July 2015, Dr Mike Durkin, National Director for Patient Safety, is working with the Chief Nursing Officer to complete the work started by NICE on safe staffing levels. Their work will draw on evidence and expert advice from England and internationally, and will be reviewed independently by NICE, the Chief Inspector of hospitals, and Sir Robert Francis to ensure it meets the high standards of care the NHS aspires to.</p><p>The programme includes revision of the NQB 2013 guidance to take account of further developments in the evidence base, the need to look beyond acute settings, new models of care leading from the Five Year Forward View and the need for providers to secure both safe staffing and greater efficiency.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name NQB guidance on safe staffing.pdf title National Quality Board safe staffing guidance 2 file name NICE safe staffing Guidance.pdf title NICE safe staffing guidance grouped question UIN HL5219 HL5221 HL5222 question first answered 01/02/2016 15:01:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

445812

	registered interest
	date	19/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what research has been commissioned or published showing the correlation between nursing numbers and (1) patient outcomes, and (2) patient mortality, in England.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL5222
	answer	answer is ministerial correction date of answer 01/02/2016 answer text <p>The Government is committed to supporting National Health Service trusts to put in place sustained safe staffing by using their resources as effectively as possible for patients.</p><p>Hospitals should be able to demonstrate that they are able to ensure safe, quality care for patients and that they are making the best use of resources. This should take account of patient acuity and dependency, time of day and local factors. It is therefore important for providers to take a rounded view, looking at staffing in a flexible way which is focused on the quality of care, patient safety and efficiency rather than just numbers and ratios of staff.</p><p> </p><p>The responsibility for both safe staffing and efficiency rests, as it has always done, with provider Boards.</p><p> </p><p>Comprehensive lists of research commissioned and published, of criteria in all European Union countries, Australia and the United States, each of which have a variety of systems in operation, and of discussions held by United Kingdom officials to compare patient outcomes in those countries with outcomes in England, could only be obtained at disproportionate cost.</p><p> </p><p>However, the 2013 National Quality Board (NQB) guidance on safe staffing issued in 2013 <em>How to ensure the right people, with the right skills, are in the right place at the right time: A guide to nursing, midwifery and care staffing capacity and capability, </em>referred to a number of sources of evidence on this issue. The National Institute of Health and Care Excellence (NICE) safe staffing guideline <em>Safe staffing for nursing in adult inpatient wards in acute hospitals, July 2014</em> set out the evidence and expert papers, including international evidence, that was considered in preparing the guideline. A copy of the NQB guidance and the NICE guideline are attached.</p><p> </p><p>In addition, The Department’s National Institute for Health Research (NIHR) commissions research evidence to improve the quality, accessibility and organisation of health services through the NIHR Health Services and Delivery Research programme. Current research of particular relevance to the relationship between nurse staffing levels and patient outcomes and mortality includes:</p><p> </p><p>- a study on nurse staffing levels, missed vital signs observations and mortality in hospital wards; and</p><p> </p><p>- a study on the future of 24/7 care: investigating the links between staffing levels, patient access and inequalities in health outcomes. <br></p><p>As announced by the Secretary of State on 16 July 2015, Dr Mike Durkin, National Director for Patient Safety, is working with the Chief Nursing Officer to complete the work started by NICE on safe staffing levels. Their work will draw on evidence and expert advice from England and internationally, and will be reviewed independently by NICE, the Chief Inspector of hospitals, and Sir Robert Francis to ensure it meets the high standards of care the NHS aspires to.</p><p>The programme includes revision of the NQB 2013 guidance to take account of further developments in the evidence base, the need to look beyond acute settings, new models of care leading from the Five Year Forward View and the need for providers to secure both safe staffing and greater efficiency.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name NQB guidance on safe staffing.pdf title National Quality Board safe staffing guidance 2 file name NICE safe staffing Guidance.pdf title NICE safe staffing guidance grouped question UIN HL5219 HL5220 HL5221 question first answered 01/02/2016 15:01:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

445811

	registered interest
	date	19/01/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government  what are the criteria for safe staffing levels for qualified nurses in (1) EU countries, (2) the US, and (3) Australia, and what discussions UK officials have had about comparing patient outcomes in those countries with those in England.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL5221
	answer	answer is ministerial correction date of answer 01/02/2016 answer text <p>The Government is committed to supporting National Health Service trusts to put in place sustained safe staffing by using their resources as effectively as possible for patients.</p><p>Hospitals should be able to demonstrate that they are able to ensure safe, quality care for patients and that they are making the best use of resources. This should take account of patient acuity and dependency, time of day and local factors. It is therefore important for providers to take a rounded view, looking at staffing in a flexible way which is focused on the quality of care, patient safety and efficiency rather than just numbers and ratios of staff.</p><p> </p><p>The responsibility for both safe staffing and efficiency rests, as it has always done, with provider Boards.</p><p> </p><p>Comprehensive lists of research commissioned and published, of criteria in all European Union countries, Australia and the United States, each of which have a variety of systems in operation, and of discussions held by United Kingdom officials to compare patient outcomes in those countries with outcomes in England, could only be obtained at disproportionate cost.</p><p> </p><p>However, the 2013 National Quality Board (NQB) guidance on safe staffing issued in 2013 <em>How to ensure the right people, with the right skills, are in the right place at the right time: A guide to nursing, midwifery and care staffing capacity and capability, </em>referred to a number of sources of evidence on this issue. The National Institute of Health and Care Excellence (NICE) safe staffing guideline <em>Safe staffing for nursing in adult inpatient wards in acute hospitals, July 2014</em> set out the evidence and expert papers, including international evidence, that was considered in preparing the guideline. A copy of the NQB guidance and the NICE guideline are attached.</p><p> </p><p>In addition, The Department’s National Institute for Health Research (NIHR) commissions research evidence to improve the quality, accessibility and organisation of health services through the NIHR Health Services and Delivery Research programme. Current research of particular relevance to the relationship between nurse staffing levels and patient outcomes and mortality includes:</p><p> </p><p>- a study on nurse staffing levels, missed vital signs observations and mortality in hospital wards; and</p><p> </p><p>- a study on the future of 24/7 care: investigating the links between staffing levels, patient access and inequalities in health outcomes. <br></p><p>As announced by the Secretary of State on 16 July 2015, Dr Mike Durkin, National Director for Patient Safety, is working with the Chief Nursing Officer to complete the work started by NICE on safe staffing levels. Their work will draw on evidence and expert advice from England and internationally, and will be reviewed independently by NICE, the Chief Inspector of hospitals, and Sir Robert Francis to ensure it meets the high standards of care the NHS aspires to.</p><p>The programme includes revision of the NQB 2013 guidance to take account of further developments in the evidence base, the need to look beyond acute settings, new models of care leading from the Five Year Forward View and the need for providers to secure both safe staffing and greater efficiency.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name NQB guidance on safe staffing.pdf title National Quality Board safe staffing guidance 2 file name NICE safe staffing Guidance.pdf title NICE safe staffing guidance grouped question UIN HL5219 HL5220 HL5222 question first answered 01/02/2016 15:01:42 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

642906

	registered interest
	date	23/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses: Labour Turnover
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, for each of the years from 2010–11 to 2015–16, (1) how many UK-trained nurses were admitted to the Nursing and Midwifery Council Register, and (2) how many UK-trained nurses left the NMC Register.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL3507
	answer	answer is ministerial correction date of answer 06/12/2016 answer text <p>The information requested is not held by the Department in the format requested. The Nursing and Midwifery Council is responsible for the registration of nurses and midwives in the United Kingdom.</p> answering member printed Lord Prior of Brampton grouped question UIN HL3508 HL3509 question first answered 06/12/2016 15:17:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

642907

	registered interest
	date	23/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses: Migrant Workers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, for each of the years from 2010–11 to 2015–16, (1) how many EU-trained nurses were admitted to the Nursing and Midwifery Council Register, and (2) how many EU-trained nurses left the NMC Register.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL3508
	answer	answer is ministerial correction date of answer 06/12/2016 answer text <p>The information requested is not held by the Department in the format requested. The Nursing and Midwifery Council is responsible for the registration of nurses and midwives in the United Kingdom.</p> answering member printed Lord Prior of Brampton grouped question UIN HL3507 HL3509 question first answered 06/12/2016 15:17:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

642908

	registered interest
	date	23/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses: Migrant Workers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, for each of the years from 2010–11 to 2015–16, (1) how many non-EU- or UK-trained nurses were admitted to the Nursing and Midwifery Council Register, and (2) how many non-EU- or UK-trained nurses left the NMC Register.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL3509
	answer	answer is ministerial correction date of answer 06/12/2016 answer text <p>The information requested is not held by the Department in the format requested. The Nursing and Midwifery Council is responsible for the registration of nurses and midwives in the United Kingdom.</p> answering member printed Lord Prior of Brampton grouped question UIN HL3507 HL3508 question first answered 06/12/2016 15:17:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4151 label Biography information for Lord Willis of Knaresborough